ID

33905

Descripción

A Study Of PF-05212384 Plus Irinotecan Vs Cetuximab Plus Irinotecan In Patients With KRAS And NRAS Wild Type Metastatic Colorectal Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01925274

Link

https://clinicaltrials.gov/show/NCT01925274

Palabras clave

  1. 6/1/19 6/1/19 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

6 de enero de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Metastatic Colorectal Cancer NCT01925274

Eligibility Metastatic Colorectal Cancer NCT01925274

Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
kras and nras wild type metastatic colorectal cancer
Descripción

Secondary malignant neoplasm of large intestine KRAS Wild Type | Secondary malignant neoplasm of large intestine NRAS Wild Type

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0346973
UMLS CUI [1,2]
C1537502
UMLS CUI [1,3]
C1883559
UMLS CUI [2,1]
C0346973
UMLS CUI [2,2]
C0809246
UMLS CUI [2,3]
C1883559
progression following treatment for colorectal cancer with irinotecan, oxaliplatin and fluoropyrimidine therapy in the metastatic setting.
Descripción

Disease Progression | Status post Treatment Secondary malignant neoplasm of large intestine | irinotecan | oxaliplatin | fluoropyrimidine

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0242656
UMLS CUI [2,1]
C0231290
UMLS CUI [2,2]
C0087111
UMLS CUI [2,3]
C0346973
UMLS CUI [3]
C0123931
UMLS CUI [4]
C0069717
UMLS CUI [5]
C0596581
eastern cooperative oncology group [ecog] performance status of 0, 1, or 2
Descripción

ECOG performance status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1520224
at least one measurable lesion by response evaluation criterion in solid tumors [recist]
Descripción

Measurable lesion Quantity

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1513041
UMLS CUI [1,2]
C1265611
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
more than 2 prior cytotoxic chemotherapy regimens for metastatic colorectal cancer.
Descripción

Cytotoxic Chemotherapy Quantity Secondary malignant neoplasm of large intestine

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0677881
UMLS CUI [1,2]
C1265611
UMLS CUI [1,3]
C0346973
prior treatment with a pi3k, mtor, akt or egfr inhibitor
Descripción

PI3K Inhibitor | mTOR Inhibitor | AKT1 gene Inhibitor | AKT2 gene Inhibitor | AKT3 gene Inhibitor | EGFR inhibitor

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1519050
UMLS CUI [2]
C2746052
UMLS CUI [3,1]
C0812228
UMLS CUI [3,2]
C1999216
UMLS CUI [4,1]
C0812230
UMLS CUI [4,2]
C1999216
UMLS CUI [5,1]
C1332074
UMLS CUI [5,2]
C1999216
UMLS CUI [6]
C1443775
patients who have discontinued treatment with prior irinotecan therapy due to toxicity.
Descripción

Irinotecan Discontinued | Etiology Toxicity

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0123931
UMLS CUI [1,2]
C1444662
UMLS CUI [2,1]
C0015127
UMLS CUI [2,2]
C0600688
prior radiation to the pelvis or abdomen
Descripción

Radiotherapy to pelvis | Radiotherapy to abdomen

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1536155
UMLS CUI [2]
C1997554
patients with history of interstitial lung disease.
Descripción

Lung Diseases, Interstitial

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0206062

Similar models

Eligibility Metastatic Colorectal Cancer NCT01925274

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Secondary malignant neoplasm of large intestine KRAS Wild Type | Secondary malignant neoplasm of large intestine NRAS Wild Type
Item
kras and nras wild type metastatic colorectal cancer
boolean
C0346973 (UMLS CUI [1,1])
C1537502 (UMLS CUI [1,2])
C1883559 (UMLS CUI [1,3])
C0346973 (UMLS CUI [2,1])
C0809246 (UMLS CUI [2,2])
C1883559 (UMLS CUI [2,3])
Disease Progression | Status post Treatment Secondary malignant neoplasm of large intestine | irinotecan | oxaliplatin | fluoropyrimidine
Item
progression following treatment for colorectal cancer with irinotecan, oxaliplatin and fluoropyrimidine therapy in the metastatic setting.
boolean
C0242656 (UMLS CUI [1])
C0231290 (UMLS CUI [2,1])
C0087111 (UMLS CUI [2,2])
C0346973 (UMLS CUI [2,3])
C0123931 (UMLS CUI [3])
C0069717 (UMLS CUI [4])
C0596581 (UMLS CUI [5])
ECOG performance status
Item
eastern cooperative oncology group [ecog] performance status of 0, 1, or 2
boolean
C1520224 (UMLS CUI [1])
Measurable lesion Quantity
Item
at least one measurable lesion by response evaluation criterion in solid tumors [recist]
boolean
C1513041 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
Cytotoxic Chemotherapy Quantity Secondary malignant neoplasm of large intestine
Item
more than 2 prior cytotoxic chemotherapy regimens for metastatic colorectal cancer.
boolean
C0677881 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0346973 (UMLS CUI [1,3])
PI3K Inhibitor | mTOR Inhibitor | AKT1 gene Inhibitor | AKT2 gene Inhibitor | AKT3 gene Inhibitor | EGFR inhibitor
Item
prior treatment with a pi3k, mtor, akt or egfr inhibitor
boolean
C1519050 (UMLS CUI [1])
C2746052 (UMLS CUI [2])
C0812228 (UMLS CUI [3,1])
C1999216 (UMLS CUI [3,2])
C0812230 (UMLS CUI [4,1])
C1999216 (UMLS CUI [4,2])
C1332074 (UMLS CUI [5,1])
C1999216 (UMLS CUI [5,2])
C1443775 (UMLS CUI [6])
Irinotecan Discontinued | Etiology Toxicity
Item
patients who have discontinued treatment with prior irinotecan therapy due to toxicity.
boolean
C0123931 (UMLS CUI [1,1])
C1444662 (UMLS CUI [1,2])
C0015127 (UMLS CUI [2,1])
C0600688 (UMLS CUI [2,2])
Radiotherapy to pelvis | Radiotherapy to abdomen
Item
prior radiation to the pelvis or abdomen
boolean
C1536155 (UMLS CUI [1])
C1997554 (UMLS CUI [2])
Lung Diseases, Interstitial
Item
patients with history of interstitial lung disease.
boolean
C0206062 (UMLS CUI [1])

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial